Effects of an estrogen receptor antagonist on proliferation, prolactin secretion and growth factor expression in the MMQ pituitary prolactinoma cell line

Journal of Clinical Neuroscience

Volumn 18, Issue 12, 2011, Pages 1694-1698

  Leng, Lige ^a,b   Zhang, Yazhuo ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Estrogen receptor ; Fulvestrant; MMQ; Prolactinoma

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH FACTOR; PROLACTIN; PROTEIN BCL 2; VASCULOTROPIN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; HUMANS; MATRIX METALLOPROTEINASE 9; PITUITARY GLAND; PROLACTIN; PROTO-ONCOGENE PROTEINS C-BCL-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 82155166339     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2011.06.013     Document Type: Article

References (24)

1. B.E. Henderson, R. Ross, and L. Bernstein Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award lecture Cancer Res 48 1988 246 253 (Pubitemid 18045752)
2. S. Melmed Mechanisms for pituitary tumorigenesis: the plastic pituitary J Clin Invest 112 2003 1603 1618 (Pubitemid 38063716)
3. I. Persson Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings J Steroid Biochem Mol Biol 74 2000 357 364 (Pubitemid 32126247)
4. R.V. Lloyd Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study Am J Pathol 113 2003 198 206
5. R.Y. Osamura, and K. Watanabe Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine Acta Pathol Jpn 36 1986 1131 1137 (Pubitemid 17173744)
6. C. Phelps, and W.C. Hymer Characterization of estrogen-induced adenohypophyseal tumors in the Fischer 344 rat Neuroendocrinology 37 1983 23 31 (Pubitemid 13071802)
7. D. Cracchiolo, J.W. Swick, and L. McKiernan Estrogen-dependent growth of a rat pituitary tumor involves, but does not require, a high level of vascular endothelial growth factor Biol Med 227 2002 492 499
8. N. Egashira, T. Minematsu, and S. Miyai Pituitary changes in Prop1 transgenic mice: hormone producing tumors and signet-ring type gonadotropes Acta Histochem Cytochem 41 2005 47 57 (Pubitemid 351904791)
9. R.Y. Osamura, N. Egashira, and H. Kajiya Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution Acta Histochem Cytochem 42 2009 95 104
10. K.A. Elias, and R.I. Weiner Direct arterial vascularization of estrogen-induced prolactin secreting anterior pituitary tumors Proc Natl Acad Sci 1984 4549 4553 (Pubitemid 14055929)
11. K.A. Elias, and R.I. Weiner Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats Endocrinology 120 1984 617 621 (Pubitemid 17020416)
12. O. Gomez, and J.A. Balsa Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen Endocrinology 144 2003 4403 4409 (Pubitemid 37204839)
13. A.A. Kemeny, J. Jakubowski, and A. Stawowy Changes of blood flow in oestrogen-induced hyperplastic anterior pituitary lobe following bromocriptine administration Br J Neurosurg 1 1987 243 250 (Pubitemid 18065574)
14. K.A. Elias, and R.I. Weiner Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats Endocrinology 120 1987 617 621 (Pubitemid 17020416)
15. A.M. Judd, I.S. Login, and K. Kovacs Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine Endocrinology 123 1998 2341 2350
16. A.E. Wakeling, M. Dukes, and J. Bowler A potent specific pure antiestrogen with clinical potential Cancer Res 51 1998 3867 3873
17. H. Lv, C. Li, and S. Gui Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line J Neurooncol 102 2011 237 245
18. Lv H, Li C, Gui S, et al. Expression of estrogen receptor α and growth factors in human prolactinoma and its correlation with clinical features and gender. J Endocrinol Invest 2011 [Epub ahead of print].
19. D. Sambaziotis, N. Kapranos, and G. Kontogeorgos Correlation of loci-2 and bax with apoptosis in human pituitary adenomas Pituitary 6 2003 127 133 (Pubitemid 38159560)
20. N. Ferrara Vascular endothelial growth factor and the regulation of angiogenesis Recent Prog Horm Res 55 2000 15 35
21. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676 (Pubitemid 36749215)
22. S.M. Hyder, Z. Nawaz, and C. Chiappetta Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor Cancer Res 60 2000 3183 3190 (Pubitemid 30407915)
23. A.L. Ochoa, N.A. Mitchner, and C.D. Paynter Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen J Endocrinol 165 2000 483 492 (Pubitemid 30341097)
24. S. Vidal, R.V. Lloyd, and L. Moya Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary J Histochem Cytochem 50 2002 533 540 (Pubitemid 34250592)